E-health platform Eucalyptus raises $22.2m in Series B round

Funds will be used to build out its behavioural health and chronic care modules.

Australian telehealth platform Eucalyptus has raised a $22.2m (A$30m) Series B funding, led by Silicon Valley-based NewView Capital and with participation from existing investors Blackbird Ventures and W23, and new investor AirTree Ventures, a press release revealed.

The company plans to use the new round of funding to build out the behavioural health and chronic care modules of the platform, aiming to support brands in weight management, diabetes, and mental health.

Eucalyptus is said to be the largest vertically integrated telehealth platform in Australia, serving more than 200,000 patients. Since its founding in 2019, Eucalyptus has launched four brands that serve contraception and fertility, skincare, men's health and sexual wellness.

With the funding, Ravi Viswanathan, the founder and managing partner of NewView Capital, will be joining the Eucalyptus board.